You are here

Home › Long COVID: U.S. government to test Pfizer's Paxlovid for helping patients › Long COVID: U.S. government to test Pfizer's Paxlovid for helping patients

Long COVID: U.S. government to test Pfizer's Paxlovid for helping patients

Primary tabs

Long COVID: U.S. government to test Pfizer's Paxlovid for helping patients

Thu, 2022-10-27 18:48 — mike kraft
U.S. government to test Pfizer's Paxlovid for long COVID The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's antiviral drug Paxlovid as the first treatment it will study in patients with long COVID, organizers of the study said on Thursday. Julie Steenhuysen Reuters

...

The trial will investigate a leading theory of the cause of long COVID, which holds that fragments of the virus persist in the tissues of some individuals, causing prolonged symptoms.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease
Hospitals
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks